Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial

Reduced DPP4 activity improves insulin signaling in primary human adipocytes

(2016) Diana Röhrborn et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A concise review of the bioanalytical methods for the quantitation of sitagliptin, an important dipeptidyl peptidase-4 (DPP4) inhibitor, utilized for the characterization of the drug

(2016) P. S. Suresh et al.   BIOMEDICAL CHROMATOGRAPHY

Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial

(2016) Yaeko Kondo et al.   Diabetology & Metabolic Syndrome

The Relationship between Retinol-Binding Protein 4 Concentrations and Gestational Diabetes Mellitus in Chinese Women

(2015) Mengkai Du et al.   GYNECOLOGIC AND OBSTETRIC INVESTIGATION

Circulating retinol-binding protein 4 levels in gestational diabetes mellitus: a meta-analysis of observational studies

(2015) Qi-Tao Huang et al.   GYNECOLOGICAL ENDOCRINOLOGY

Glyburide in Women With Mild Gestational Diabetes

(2015) Brian M. Casey et al.   OBSTETRICS AND GYNECOLOGY

RBP4 Gene Variants Are Associated with Insulin Resistance in Women with Previous Gestational Diabetes

(2014) Renata Saucedo et al.   DISEASE MARKERS

Significance of RBP4 in patients with gestational diabetes mellitus: a case-control study of Han Chinese women

(2014) Liang Zhaoxia et al.   GYNECOLOGICAL ENDOCRINOLOGY

Factors predictive of macrosomia in pregnancies with a positive oral glucose challenge test: Importance of fasting plasma glucose

(2013) H. Legardeur et al.   DIABETES & METABOLISM

Adipose Dipeptidyl Peptidase-4 and Obesity: Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro

(2013) H. Sell et al.   DIABETES CARE

Diagnosis and Classification of Diabetes Mellitus

(2013)   DIABETES CARE

A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function

(2012) Giuseppe Derosa et al.   EXPERT OPINION ON PHARMACOTHERAPY

Mechanisms for the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes

(2012) Elza Muscelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Retinol-binding protein 4, insulin resistance and pregnancy

(2012) Viroj Wiwanitkit   METABOLISM-CLINICAL AND EXPERIMENTAL

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

(2011) D. Lamers et al.   DIABETES

Retinol-binding protein 4 is not associated with insulin resistance in pregnancy

(2011) Weerapan Khovidhunkit et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria

(2010) Nawel Hamza et al.   JOURNAL OF ETHNOPHARMACOLOGY

Retinol-Binding Protein 4 in Patients with Gestational Diabetes Mellitus

(2010) Katharina Klein et al.   JOURNAL OF WOMENS HEALTH

A customized standard to assess fetal growth in a US population

(2009) Jason Gardosi et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: Negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1)

(2008) Krzysztof C. Lewandowski et al.   GYNECOLOGICAL ENDOCRINOLOGY

High Plasma Retinol Binding Protein-4 and Low Plasma Adiponectin Concentrations Are Associated with Severity of Glucose Intolerance in Women with Previous Gestational Diabetes Mellitus

(2008) Sung Hee Choi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Normal and abnormal maternal metabolism during pregnancy

(2008) David R. Hadden et al.   Seminars in Fetal & Neonatal Medicine